BDRX: Biodexa Pharmaceuticals plc - American Depositary Shares

BDRX新闻

• Investing 11:06 Biodexa advances FAP treatment with phase 3 trial initiation
• Benzinga 10:59 How Biodexa Is Racing To Get Its Phase 3 Program In FAP Under Way And Gain First-Mover Advantage In A $7B Addressable Market - Biodexa Pharmaceuticals (NASDAQ:BDRX), Palvella Therapeutics (NASDAQ:PVLA)
• TipRanks 12:46 Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested - TipRanks.com
• Investing 20:33 Biodexa Pharmaceuticals to implement 1:10 ADR ratio change
• Investing 12:51 Biodexa files European clinical trial application for FAP treatment
• Investing 12:48 Results of Annual General Meeting
• Investing 12:44 Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
• Investing 11:06 Biodexa enrolls first patient in type 1 diabetes drug trial
• Benzinga 11:00 Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study - Biodexa Pharmaceuticals (NASDAQ:BDRX), Pfizer (NYSE:PFE)
• Investing 20:40 Biodexa Pharmaceuticals changes share nominal value
• Investing 20:48 Biodexa shareholders approve all resolutions at general meeting
• Investing 12:44 Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes
• Investing 12:44 Shareholder Update
• Benzinga 09:09 Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - 180 Life Sciences (NASDAQ:ATNF), Biodexa Pharmaceuticals (NASDAQ:BDRX)
• Investing 12:33 Biodexa secures additional $3M for cancer drug trial
• Investing 20:44 Biodexa Pharmaceuticals adjusts warrant exercise price